John P. Saharek

John Saharek serves as President and Chief Executive Officer of ImprimisRx® - A Harrow Company since January 2024, having previously held the role of Chief Commercial Officer at Harrow since October 2022. John's extensive experience includes leadership positions at ImprimisRx and Imprimis Pharmaceuticals, focusing on commercial activities such as formulation portfolio management, market access, sales, and marketing. Prior roles include Head of US Marketing and Strategy at ThromboGenics, National Director of Sales and Reimbursement at the same company, Vice President of Business Development at SurModics Pharmaceuticals, and various marketing roles at Bausch & Lomb, Instrumentation Laboratory, and Boehringer Mannheim (now Roche). John Saharek holds an MBA in Finance from the University of Hartford and a BA in Business from Central Connecticut State University.